SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000843
Filing Date
2024-05-15
Accepted
2024-05-14 20:25:14
Documents
61
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nnvc-20240331x10q.htm   iXBRL 10-Q 1494549
2 EX-31.1 nnvc-20240331xex31d1.htm EX-31.1 11524
3 EX-31.2 nnvc-20240331xex31d2.htm EX-31.2 11018
4 EX-32.1 nnvc-20240331xex32d1.htm EX-32.1 6559
5 EX-32.2 nnvc-20240331xex32d2.htm EX-32.2 7506
  Complete submission text file 0001410578-24-000843.txt   5525016

Data Files

Seq Description Document Type Size
6 EX-101.SCH nnvc-20240331.xsd EX-101.SCH 41011
7 EX-101.CAL nnvc-20240331_cal.xml EX-101.CAL 29413
8 EX-101.DEF nnvc-20240331_def.xml EX-101.DEF 160638
9 EX-101.LAB nnvc-20240331_lab.xml EX-101.LAB 317616
10 EX-101.PRE nnvc-20240331_pre.xml EX-101.PRE 233418
65 EXTRACTED XBRL INSTANCE DOCUMENT nnvc-20240331x10q_htm.xml XML 853224
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36081 | Film No.: 24946688
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)